In contrast, the therapeutic efficacy of the 10 μg dose of the Xcl1-E6E7+mIL-9 plasmid DNA vaccine was notably reduced compared to the 25 μg dose, with none of the five mice experiencing complete tumor remission (Figure 5C). Here, XCL1 is linked to neoplasm.